Showing results (331-340 of 445) with videos related to

Sort By:
Pageof 45
International Journal of Pediatrics|July 18, 2013
Maternal BMI, IGF-I Levels, and Birth Weight in African American and White InfantsAdriana C Vidal, Amy P Murtha, Susan K Murphy, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2010
Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantationRegis Peffault de Latour, Duncan Purtill, Annalisa Ruggeri, et al.
The New England Journal of Medicine|November 26, 1998
Outcomes among 562 recipients of placental-blood transplants from unrelated donorsP Rubinstein, C Carrier, A Scaradavou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology GroupStacey L Berg, Susan M Blaney, Meenakshi Devidas, et al.
Cancer Causes & Control : CCC|March 7, 2012
Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weightCathrine Hoyo, Kimberly Fortner, Amy P Murtha, et al.
The New England Journal of Medicine|June 16, 2001
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donorsM J Laughlin, J Barker, B Bambach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndromeJaap Jan Boelens, Vanderson Rocha, Mieke Aldenhoven, et al.
Molecular Cancer Therapeutics|January 22, 2011
sFLT01: a novel fusion protein with antiangiogenic activityRebecca G Bagley, Leslie Kurtzberg, William Weber, et al.
Journal of Pediatric Hematology/Oncology|March 11, 2014
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology GroupRichard L Tower, Tamekia L Jones, Bruce M Camitta, et al.
Pageof 45